Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-06

Clinical Trial Update: Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial update of the Buprenorphine Transdermal System for pain. It reports safety, pharmacokinetics, and efficacy with results posted in July 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPRENORPHINE TRANSDERMAL SYSTEM (buprenorphine)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2017-07-06